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Background: Increased expression of inducible nitric oxide synthase in inflamed tonsils has
been reported. Our preliminary observation was the first to demonstrate that increased
exhaled NO level may occur in patients with tonsillitis.
Objective: To extend the observation scope, the same group of patients was examined for NO
exhaled after tonsillectomy.
Materials and Methods: Exhaled oral NO level was measured with Niox Mino analyzer, six-
seven months after tonsillectomy in 27 non-atopic patients who suffered from recurrent tonsil-
litis and in 35 healthy non-atopic subjects.
Results: After tonsillectomy, exhaled NO levels were significantly reduced as compared to the
preoperative period values and did not differ significantly from those of the healthy subjects.
Conclusions: The results support a finding of the elevated exhaled NO consequent to NO
production in chronically inflamed tonsils, but whether NO plays any role in the pathogenesis
of tonsillitis or is merely a by-product of another process, needs to be determined.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
Exhaled NO is produced within the respiratory tract and can
be a sensitive marker of the asthmatic airway inflammation,inical Department of Internal
unology, ul. Ceglana 35, 40-
37333.
.pl (A. Kasperska-Zajac).
0 Elsevier Ltd. All rights reservednot specific however for the disease,1,2 as the increased
level of exhaled oral NO has been observed in other respi-
ratory tract diseases.3e6 However, not all sources respon-
sible for higher NO level in exhaled air have been identified
yet. Our preliminary observation was the first to evaluate
the significantly increased exhaled NO level in patients
suffering from recurrent tonsillitis as compared with the
healthy subjects.7 In order to confirm the observation
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Figure 1 Exhaled level of NO in patients suffered from
recurrent tonsillitis and healthy subjects.
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group of patients.
Materials and methods
In thirty two non-atopic, non-smoking patients (18 women,
14 men; median age 28 years, range 18e50 years) with
a history of frequent tonsillitis episodes (at least 4 per
annum) occurring over many years requiring administration
of frequent antibiotic courses, exhaled oral NO levels were
measured 24 h before tonsillectomy (described earlier).7 4
patients had small tonsils, which were either completely
included in the tonsillar fossa, or minimally visible beyond
the anterior tonsillar pillars. The remaining patients had
tonsils taking up to 50% of their oropharyngeal airway. The
examined patients were infection-free for at least one
month prior to surgery and did not receive any antibiotics
during this period. They did not show any features of nasal
or pharyngeal inflammation (history and nasopharynx
examination) and blood inflammatory markers (leukocy-
tosis, C reactive protein, erythrocyte sedimentation rate)
were within normal range. The patients manifested no
clinical symptoms of bronchial asthma or any atopic
features and the spirometry results were normal. In addi-
tion, chest radiography was performed to exclude other
pulmonary diseases. Apart from the tonsillar symptoms, all
patients were healthy and did not receive any medication.
All removed tonsils were histologically evaluated. In the
twenty seven patients, of the same group, exhaled oral NO
was examined again 6e7 months after tonsillectomy; the
remaining five failed to report for the follow-up. All the
patients were healthy and did not receive any medication
within at least 4 weeks. Also, the same group of thirty five
non-atopic, non-smoking healthy subjects (20 women, 15
men; median age 30 years, range 18e49) were included in
the follow-up examination for another NO evaluation.
Skin prick tests
Allergic status was evaluated by skin prick testing with
a panel of common inhalant allergens [grass, weed and tree
pollens, domestic animals (cat, dog, rabbit, hamster, and
guinea pig), molds, Dermathophagoides pteronyssinus,
Dermathophagoides farinae] (Allergopharma, Reinbek,
Germany). Saline and histamine solutions were used as
negative and positive controls, respectively. A wheal
diameter greater by 3 mm than the negative control was
accepted as a positive result.
Measurement of NO
Exhaled oral NO levels were measured in triplicate using
Niox Mino analyzer (Aerocrine AB, Solna e Sweden). The
level of NO is expressed in parts per billion (ppb).
Statistical analysis
The levels of exhaled nitric oxide were compared between
patients and the healthy controls using the ManneWhitney
test. For comparisons within the same individuals overtime, the Wilcoxon matched pairs test was used. Data are
presented as median and range. P values below 0.05 were
considered significant.
Results
Exhaled NO level following tonsillectomy was significantly
lower as compared with the values observed before
tonsillectomy and did not differ significantly as compared
to the healthy subjects (median value and range: 18.0
(8.0e25.0), 23.0 (6.0e50.0) and 16.0 (8.0e26.0) ppb,
respectively) (Fig. 1).
Discussion
NO is a free-radical generated from L-arginine through the
NO synthases (NOS), including inducible (iNOS), expression
which is induced by various proinflammatory mediators and
lipopolysaccharides.8 It has been suggested that iNOS and
NO metabolite formations may have an important role in
pathogenesis of the recurrent tonsillitis.9
We observed the elevated, exhaled NO level reduced
remarkably the following tonsillectomy in patients
suffering from recurrent tonsillitis. The present observation
taken along with our earlier results showed that levels of
exhaled NO were elevated in patients with recurrent
tonsillitis and regained the control levels after tonsillec-
tomy, suggesting that chronic inflammatory tonsil disease
might increase the NO level in exhaled air. On the basis of
the earlier studies,9,10 it seems likely that NO formed by
iNOS in the tonsils may be responsible for the increased
formation of NO in patients with recurrent tonsillitis, which
represents a chronic inflammatory diseases of tonsils.
However, a source of increased NO release in tonsils is
still unknown. Probably, different cell sources play a role in
this process. In chronically inflamed tonsillar tissues iNOS
expression was found mainly in the mucosal epithelium and
subepitheial layer, vascular endothelium and infiltrating
cells, which are likely to be leukocytes.9 However, the
parenchyma of the tonsils, where T- and B-cell clones are
located, showed little iNOS immunoreactivity. Normal
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mucosal epithelium. The subepithelial layer and paren-
chyma showed almost no immunoreactivity for iNOS.9 In
addition, expression of iNOS has been reported in macro-
phages of hyperplastic but not normal tonsils.10 It has been
speculated, that NO directly or via its metabolites, may
play a double role in inflamed tonsils. On one hand it has
a positive effect performing as a defence mechanism
against microorganisms, yet on the other, it appears
unfavourable causing the cell and tissue damage which may
result in increased hyperresponsiveness of tonsils.9,10
Conclusions
The results support a finding of the elevated exhaled NO
consequent to inflammation in the tonsillar tissue, but
whether NO plays any role in the pathogenesis of tonsillitis
or is merely a by-product of another process, needs to be
determined. At present, the major sources and the func-
tional role of increased NO release in tonsillitis are
unknown and still highly speculative.
It is important for the clinicians to acknowledge that
tonsillitis may influence the level of the exhaled nitric
oxide. It would be interesting to investigate exhaled NO
level in other types of tonsillitis, including acute tonsillar
inflammation.Conflict of interest
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